Literature DB >> 26614685

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease.

Marcus Harbord1, Vito Annese2, Stephan R Vavricka3, Matthieu Allez4, Manuel Barreiro-de Acosta5, Kirsten Muri Boberg6, Johan Burisch7, Martine De Vos8, Anne-Marie De Vries9, Andrew D Dick10, Pascal Juillerat11, Tom H Karlsen6, Ioannis Koutroubakis12, Peter L Lakatos13, Tim Orchard14, Pavol Papay15, Tim Raine16, Max Reinshagen17, Diamant Thaci18, Herbert Tilg19, Franck Carbonnel20.   

Abstract

Entities:  

Keywords:  Crohn’s disease; ECCO; extra-intestinal manifestation; inflammatory bowel disease; ulcerative colitis

Mesh：

Year:  2015        PMID： 26614685      PMCID： PMC4957476          DOI： 10.1093/ecco-jcc/jjv213

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  147 in total

1.  Vedolizumab-Induced De Novo Extraintestinal Manifestations.

Authors:  Liege I Diaz; Tara Keihanian; Ingrid Schwartz; Su Bin Kim; Fernando Calmet; Maria Alejandra Quintero; Maria T Abreu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-02

Review 2.  Oral pathology in inflammatory bowel disease.

Authors:  Miranda Muhvić-Urek; Marija Tomac-Stojmenović; Brankica Mijandrušić-Sinčić
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

3.  Bacteroides thetaiotaomicron Ameliorates Colon Inflammation in Preclinical Models of Crohn's Disease.

Authors:  Margaret Delday; Imke Mulder; Elizabeth T Logan; George Grant
Journal:  Inflamm Bowel Dis       Date:  2019-01-01       Impact factor: 5.325

Review 4.  Resolution of Crohn's disease.

Authors:  Heike Schmitt; Clemens Neufert; Markus F Neurath; Raja Atreya
Journal:  Semin Immunopathol       Date:  2019-09-24       Impact factor: 9.623

5.  Functional polymorphisms of the receptor for the advanced glycation end product promoter gene in inflammatory bowel disease: a case-control study.

Authors:  Rachele Ciccocioppo; Sara Bozzini; Elena Betti; Venerina Imbesi; Catherine Klersy; Lucia Sukovska Lakyova; Lukas Sukovsky; Jozef Benacka; Peter Kruzliak; Gino Roberto Corazza; Antonio Di Sabatino; Colomba Falcone
Journal:  Clin Exp Med       Date:  2019-06-07       Impact factor: 3.984

6.  Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease.

Authors:  Fanni Rencz; Peter L Lakatos; László Gulácsi; Valentin Brodszky; Zsuzsanna Kürti; Szilvia Lovas; János Banai; László Herszényi; Tamás Cserni; Tamás Molnár; Márta Péntek; Károly Palatka
Journal:  Qual Life Res       Date:  2018-09-17       Impact factor: 4.147

Review 7.  [Aspects of pulmonary involvement in inflammatory bowel disease].

Authors:  A Moeser; M Lerche; H Wirtz; A Stallmach
Journal:  Internist (Berl)       Date:  2018-09       Impact factor: 0.743

Review 8.  Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease.

Authors:  Jurij Hanzel; Christopher Ma; Niels Vande Casteele; Reena Khanna; Vipul Jairath; Brian G Feagan
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

Review 9.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

10.  Chronic cough in a patient with stable ulcerative colitis: a rare but important extraintestinal manifestation of inflammatory bowel disease.

Authors:  Thomas Chad; Jeremy Brown
Journal:  BMJ Case Rep       Date:  2019-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.